Moreover, when we subcutaneously injected sorafenib-resistant Huh7 cells into sorafenib-treated nude mice, RCN1 knockdown significantly enhanced the effectiveness of sorafenib against HCC (Fig. 2C). The gene discussed is RCN1; the disease is hepatocellular carcinoma.